Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the effect of nicotinamide mononucleotide (NMN) on the body composition in elderly persons
Not Applicable
- Conditions
- healthy subjects
- Registration Number
- JPRN-UMIN000036321
- Lead Sponsor
- Department of Diabetes and Metabolic Diseases, The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
1)The subjects who take functional food that may affect the trial 2)The subjects who take more than one hour daily exercise for more than 6 months 3)The subjects with the history of serious disease (malignant neoplasms, cardiac failure and myocardial infarction ) 4)The subjects with chronic disease 5)The subjects who take medicines 6)The subjects with allergic disorders. 7)The subjects who participate in any clinical trial within 90 days of the commencement of the trial 8)The subjects judged as ineligible by clinical investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the skeletal muscle index by the bioelectrical impedance analysis
- Secondary Outcome Measures
Name Time Method 1) To evaluate the parameters related to glucose metabolism 2)To evaluate the vascular endothelial function by FMD